CHATSWORTH, Calif., July 27, 2010 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, announced today that it has signed a definitive agreement to acquire AlliedPath, Inc., a private, early stage high complexity, CLIA-certified laboratory focused on oncology and molecular diagnostics for $4.7 million in cash, with an additional earn-out up to $1.3 million subject to the achievement of specific sales and earnings targets over the next three years. The acquisition, which is subject to customary closing conditions, is expected to close on or before July 30, 2010.
